Sandoz loses bid to shield psoriasis drug
December 05, 2014 at 14:09 PM EST
Dec 5 (Reuters) - The top U.S. patent appeals court has upheld the dismissal of a lawsuit brought by Sandoz Inc that sought to shield its planned version of Amgen Inc's psoriasis and arthritis drug Enbrel from patent lawsuits.
